Biotechnology SS Boehringer Ingelheim Award for Excellence in Biotherapeutic Safety
Deadline: February 9
The Biotechnology Specialty Section (BTSS) is thrilled to announce a new award for 2018 which has been made possible by the Boehringer Ingelheim Biotherapeutic Safety Excellence Fund. The Boehringer Ingelheim Award for Excellence in Biotherapeutic Safety is intended to encourage research and training of graduate students and postdoctoral fellows in nonclinical safety sciences as applied to biotherapeutic products. Examples include (but are not limited to): biotechnology-derived proteins; gene therapies; vaccines; blood-derived products; imaging agents; molecular diagnostics; genetically-modified organics (crops, foods, and animals); biodegradable plastics; biofuels; biodefense; and bioremediation. The award recipient will be eligible for reimbursement of up to $2000 of expenses related to attendance at a biotechnology nonclinical safety-related conference or training course.
The recipient is chosen based on criteria that include quality of the training course or conference, relevance of the training course or conference to a career in nonclinical safety sciences as applied to biotherapeutic products, academic achievement, and recommendation by academic advisor. To receive reimbursement, award recipients must provide original receipts to the BTSS
and a complete reimbursement form in compliance with the SOT Reimbursement Policy
at the completion of the funded activity.
Determination of the awardee(s) will be made by the members of the BTSS awards committee.
Eligibility Criteria: 1) Enrolled as graduate student or postdoctoral fellow at an accredited institution at time of application and the time of the conference or training 2) Designation of an activity that begins no sooner than two months following the Annual Meeting 3) Completion of the training course or conference no more than one year following the deadline for which the application is submitted 4) Attendance at SOT annual meeting during the year of application.
Application Criteria: 1) Written justification of the relevance of the proposed conference or training to a future career in nonclinical safety sciences as applied to biotherapeutic products, 2) CV and evidence of current enrollment in accredited institution, 3) Supporting letter of recommendation from advisor at home institution indicating: i) approval of the applicant’s participation in the proposed activity and the relevance and value to the applicant’s educational or career goals and ii) confirmation that the applicant will attend the upcoming SOT annual meeting.
Possible eligible expenses include: Conference or Professional Workshop registration fees (Registration fee is waived for certain symposia; please contact Jacintha Shenton
for details) and travel expenses associated with attendance at the Conference or Professional Workshop. Examples of expenses that are not eligible include: Institutional administrative and/or overhead costs, tuition costs at current institution, textbooks or materials part of normal course work, SOT Annual Meeting travel or registration, SOT Membership Dues, Membership Dues for other professional organizations.
Award recipients will be reimbursed only after the activity has taken place. To receive reimbursement, original receipts (showing payment confirmation) must be provided to the BTSS
This award is made possible by the Boehringer Ingelheim Biotherapeutic Safety Excellence Endowment Fund.
Award Group: SOT